Literature DB >> 11172695

Adverse reactions to fluoroquinolones. an overview on mechanistic aspects.

A De Sarro1, G De Sarro.   

Abstract

This review focuses on the most recent research findings on adverse reactions caused by quinolone antibiotics. Reactions of the gastrointestinal tract, the central nervous system (CNS) and the skin are the most often observed adverse effects. Occasionally major events such as phototoxicity, cardiotoxicity, arthropathy and tendinitis occur, leading to significant tolerability problems. Over the years, several structure-activity and side-effect relationships have been developed, in an effort to improve overall antimicrobial efficacy while reducing undesirable side-effects. In this article we review the toxicity of fluoroquinolones, including the newer derivatives such levofloxacin, sparfloxacin, graepafloxacin and the 7-azabicyclo derivatives, trovafloxacin and moxifloxacin. A special attention is given to new data on mechanistic aspects, particularly those regarding CNS effects. In recent years extensive in vivo and in vitro experiments have been performed in an attempt to explain the neurotoxic effects of quinolones sometimes observed under therapeutic conditions. However, the molecular target or receptor for such effects is still not exactly known. Several mechanisms are thought to be responsible. The involvement of gamma-aminobutyric acid (GABA) and excitatory amino acid (EAA) neurotransmission and the kinetics of quinolones distribution in brain tissue are discussed. In addition, quinolones may interact with other drugs--theophylline and nonsteroidal antiflammatory drugs (NSAID(s))--in producing CNS effects This article provides information about the different mechanisms responsible of quinolones interaction with NSAID(s), methylxanthines, warfarin and antiacids.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172695     DOI: 10.2174/0929867013373435

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  41 in total

Review 1.  Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity.

Authors:  Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2010-06-10       Impact factor: 4.849

2.  Norfloxacin blood-brain barrier transport in rats is not affected by probenecid coadministration.

Authors:  Sandrine Marchand; Anna Forsell; Marylore Chenel; Emmanuelle Comets; Isabelle Lamarche; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Rapid reversible coma with intravenous gamma-hydroxybutyrate in a moxifloxacin-treated patient.

Authors:  Gerd Koehler; Anika Haimann; Hermann Laferl; Christoph Wenisch
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

Review 4.  Amino Acids in the Development of Prodrugs.

Authors:  Nuno Vale; Abigail Ferreira; Joana Matos; Paula Fresco; Maria João Gouveia
Journal:  Molecules       Date:  2018-09-11       Impact factor: 4.411

5.  Clarithromycin increases neuronal excitability in CA3 pyramidal neurons through a reduction in GABAergic signaling.

Authors:  Edyta K Bichler; Courtney C Elder; Paul S García
Journal:  J Neurophysiol       Date:  2016-10-12       Impact factor: 2.714

6.  Effect of Antibiotic Class on Stroke Outcome.

Authors:  Dannielle Zierath; Allison Kunze; Leia Fecteau; Kyra Becker
Journal:  Stroke       Date:  2015-07-02       Impact factor: 7.914

7.  Intrinsic versus idiosyncratic drug-induced hepatotoxicity--two villains or one?

Authors:  Robert A Roth; Patricia E Ganey
Journal:  J Pharmacol Exp Ther       Date:  2009-12-17       Impact factor: 4.030

8.  A seizure attributed to ofloxacine in a woman undergoing detoxification for alcohol dependence.

Authors:  Pierre Lahmek; Laurent Michel; Nadine Meunier; Henri-Jean Aubin
Journal:  Case Rep Med       Date:  2010-01-24

9.  Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy.

Authors:  Federico Pea; Federica Pavan; Ennio Nascimben; Claudio Benetton; Pier Giorgio Scotton; Alberto Vaglia; Mario Furlanut
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

10.  Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus.

Authors:  Timothy A Wencewicz; Timothy E Long; Ute Möllmann; Marvin J Miller
Journal:  Bioconjug Chem       Date:  2013-02-14       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.